As of 2024-12-13, the Intrinsic Value of Biovaxys Technology Corp (BIOV.CN) is
-0.10 CAD. This BIOV.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.06 CAD, the upside of Biovaxys Technology Corp is
-258.75%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.10 CAD
Intrinsic Value
BIOV.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
-0.10 - -0.10 |
-0.10 |
-258.75% |
P/E |
(0.00) - (0.00) |
(0.00) |
-101.6% |
DDM - Stable |
(0.26) - (2.37) |
(1.32) |
-2295.7% |
DDM - Multi |
(0.41) - (2.88) |
(0.71) |
-1285.9% |
BIOV.CN Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
15.36 |
Beta |
-0.21 |
Outstanding shares (mil) |
256.03 |
Enterprise Value (mil) |
14.95 |
Market risk premium |
5.10% |
Cost of Equity |
6.92% |
Cost of Debt |
5.00% |
WACC |
5.31% |